Singapore markets close in 1 hour 27 minutes
Straits Times Index
3,205.88 -11.53 (-0.36%) Nikkei
31,759.88 -97.72 (-0.31%) Hang Seng
17,809.66 +436.66 (+2.51%) FTSE 100
7,624.80 +16.72 (+0.22%) Bitcoin USD
28,219.02 +1,102.30 (+4.07%) CMC Crypto 200
605.40 +26.64 (+4.60%)
Aeglea BioTherapeutics, Inc. (AGLE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 11.46 |
| Open | 11.33 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1000 |
| Day's range | 11.10 - 12.42 |
| 52-week range | 2.66 - 39.00 |
| Volume | |
| Avg. volume | 54,956 |
| Market cap | 49.585M |
| Beta (5Y monthly) | 2.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -76.76 |
| Earnings date | 01 Nov 2023 - 06 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 17.75 |
ZacksAeglea (AGLE) Soars 329% on Acquiring Spyre Therapeutics
Aeglea's (AGLE) shares surge as it acquires Spyre Therapeutics, a private company that focuses on developing antibody therapeutics for inflammatory bowel disease.
Yahoo Finance UKTrending tickers: Aeglea | GSK | Ocado | Virgin Galactic
A reverse acquisition in biopharma, litigation over a cancer drug ends for GSK and Ocado takeover rumours are moving markets.
ZacksAeglea Biotherapeutics (AGLE) Reports Q1 Loss, Tops Revenue Estimates
Aeglea (AGLE) delivered earnings and revenue surprises of -5.26% and 16.47%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
